OMRF President Dr. Stephen Prescott says that the CDC deadline doesn’t give a lot of wiggle room.
FDA grants designations for OMRF brain tumor drug
The Oklahoma Medical Research Foundation is one step closer to beating rare forms of brain cancers.
OMRF brain tumor drug receives rare disease designations from the FDA
The drug treats fast-growing, deadly brain cancers with no effective treatment.
Bodywork: Does GoodRx live up to its name?
How does GoodRx produce such a dramatic reduction in drug prices? And shouldn’t everyone be entitled to such savings?
OMRF receives $2.2 million to study brain cells
The National Institutes of Health has awarded OMRF scientist Tommy Lewis $2.2 million to study the inner workings of brain cells.
OMRF finds clues to reversing heart dysfunction in older adults
The risk of heart failure increases as we age. OMRF is investigating why — and whether it can be stopped.
